Carnitine Levels and Carnitine Supplementation in Type I Diabetes

Completed

Conditions studied: Diabetes Mellitus, Type I, Hypoglycemia

In brief

The purpose of this study is to determine whether type I diabetics with carnitine deficiency exhibit increased numbers of hypoglycemic (low blood sugars) events and if unrecognized hypoglycemia occurs during continuous 72-hour glucose monitoring. If they are determined to have unrecognized hypoglycemia, then oral carnitine supplementation will be given to those subjects and they will be reassessed for the number of hypoglycemic events in a 72-hour glucose monitoring.

Key facts

Study ID

NCT00351234

Run by

Children's Mercy Hospital Kansas City

People needed

200

Starts

2004-10-01

Expected to finish

2007-04-01

Last updated by the study team

2012-02-28

Who can join

Age: 7 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diabetes Mellitus, Type I for greater than 2 years between the ages of 7 and 21
• currently on insulin replacement therapy

You may not qualify if…

• Patients with newly diagnosed Type I diabetes
• Patients already taking L-carnitine
• Patients who come to clinic without glucose monitors
• Patients with known seizure disorders not including hypoglycemic seizures
• Patients on metformin
• Patients with compromised renal function.

Where it is running

• The Children's Mercy Hospital — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.